|  Help  |  About  |  Contact Us

Publication : Hypoxia-Inducible Factor 1 Alpha Is Dispensable for Host Defense of Group B Streptococcus Colonization and Infection.

First Author  Lum GR Year  2021
Journal  J Innate Immun Volume  13
Issue  6 Pages  391-403
PubMed ID  34023827 Mgi Jnum  J:360398
Mgi Id  MGI:7797509 Doi  10.1159/000515739
Citation  Lum GR, et al. (2021) Hypoxia-Inducible Factor 1 Alpha Is Dispensable for Host Defense of Group B Streptococcus Colonization and Infection. J Innate Immun 13(6):391-403
abstractText  Group B Streptococcus (GBS) is a leading cause of neonatal morbidity and mortality, and the primary source of exposure is the maternal vagina. Intrapartum antibiotic prophylaxis for GBS-positive mothers has reduced the incidence of GBS early-onset disease, however, potential long-lasting influence of an antibiotic-altered neonatal microbiota, and the frequent clinical sequelae in survivors of invasive GBS infection, compels alternative treatment options for GBS. Here, we examined the role of transcription factor hypoxia-inducible factor 1 alpha (HIF-1alpha), widely recognized as a regulator of immune activation during infection, in the host response to GBS. Given the importance of endogenous HIF-1alpha for innate immune defense, and the potential utility of HIF-1alpha stabilization in promoting bacterial clearance, we hypothesized that HIF-1alpha could play an important role in coordinating host responses to GBS in colonization and systemic disease. Counter to our hypothesis, we found that GBS infection did not induce HIF-1alpha expression in vaginal epithelial cells or murine macrophages, nor did HIF-1alpha deficiency alter GBS colonization or pathogenesis in vivo. Furthermore, pharmacological enhancement of HIF-1alpha did not improve control of GBS in pathogenesis and colonization models, while displaying inhibitory effects in vaginal epithelial cytokines and immune cell killing in vitro. Taken together, we conclude that HIF-1alpha is not a prominent aspect of the host response to GBS colonization or invasive disease, and its pharmacological modulation is unlikely to provide significant benefit against this important neonatal pathogen.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

12 Bio Entities

Trail: Publication

0 Expression